Switch to:
Also traded in: Australia, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Cash to Debt 2.04
NAS:SSH's Cash to Debt is ranked lower than
52% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: 2.19 vs. NAS:SSH: 2.04 )
Ranked among companies with meaningful Cash to Debt only.
NAS:SSH' s Cash to Debt Range Over the Past 10 Years
Min: 2.04  Med: No Debt Max: No Debt
Current: 2.04
F-Score: 2
Z-Score: -21.53
M-Score: -3.53
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
ROE (%) -166.61
NAS:SSH's ROE (%) is ranked lower than
95% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. NAS:SSH: -166.61 )
Ranked among companies with meaningful ROE (%) only.
NAS:SSH' s ROE (%) Range Over the Past 10 Years
Min: -238.68  Med: -122.75 Max: -63.22
Current: -166.61
-238.68
-63.22
ROA (%) -92.52
NAS:SSH's ROA (%) is ranked lower than
89% of the 322 Companies
in the Global Medical Devices industry.

( Industry Median: 0.05 vs. NAS:SSH: -92.52 )
Ranked among companies with meaningful ROA (%) only.
NAS:SSH' s ROA (%) Range Over the Past 10 Years
Min: -216.94  Med: -110.93 Max: -58.42
Current: -92.52
-216.94
-58.42
ROC (Joel Greenblatt) (%) -4068.02
NAS:SSH's ROC (Joel Greenblatt) (%) is ranked lower than
93% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 4.17 vs. NAS:SSH: -4068.02 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
NAS:SSH' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -4851.22  Med: -3181.97 Max: -774.91
Current: -4068.02
-4851.22
-774.91
EBITDA Growth (3Y)(%) -12.00
NAS:SSH's EBITDA Growth (3Y)(%) is ranked lower than
73% of the 192 Companies
in the Global Medical Devices industry.

( Industry Median: 1.50 vs. NAS:SSH: -12.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
NAS:SSH' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -15.7 Max: 415.7
Current: -12
0
415.7
EPS Growth (3Y)(%) -9.50
NAS:SSH's EPS Growth (3Y)(%) is ranked lower than
70% of the 195 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. NAS:SSH: -9.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
NAS:SSH' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -13.7 Max: 437.7
Current: -9.5
0
437.7
» NAS:SSH's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-11-03)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

SSH Guru Trades in

Q4 2015

SSH Guru Trades in Q4 2015

Jim Simons 36,100 sh (New)
» More
Q1 2016

SSH Guru Trades in Q1 2016

Jim Simons 52,881 sh (+46.48%)
» More
Q2 2016

SSH Guru Trades in Q2 2016

Jim Simons 60,000 sh (+13.46%)
» More
» Details

Insider Trades

Latest Guru Trades with SSH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices
Compare:OTCBB:NAOV, OTCPK:CRVW, AMEX:XTNT, OTCPK:IGNG, OTCPK:MRIC, OTCPK:SNWV, OTCPK:DTXMF, NAS:EVAR, NAS:VSCP, OTCPK:BLOZF, NAS:DHRM, AMEX:HRT, OTCPK:NIMU, OTCPK:ARCRF, OTCPK:ABMT, NAS:MDVX, OTCPK:PBIO, OTCPK:PETV, NAS:MDGS, OTCPK:AROSF » details
Traded in other countries:SHC.Australia, 22S.Germany,
Sunshine Heart Inc is an early stage medical device company. It is engaged in developing, manufacturing and commercializing its C-Pulse Heart System for treatment of Class III and ambulatory Class IV heart failure.

Sunshine Heart Inc was incorporated in Delaware on August 22, 2002. The company is an early-stage medical device company engaged in developing, manufacturing and commercializing its C-Pulse Heart Assist System for treatment of Class III and ambulatory Class IV heart failure. Its C-Pulse Heart Assist System utilizes the scientific principles of intra-aortic balloon counter-pulsation applied in an extra-aortic approach to assist the left ventricle by reducing the workload required to pump blood throughout the body, while increasing blood flow to the coronary arteries. It is in the process of obtaining regulatory approvals necessary to sell its product. Combined, these potential benefits may help reverse the heart failure process or maintain the patient's current condition, thereby potentially preventing the need for later-stage heart failure devices, such as LVADs, artificial hearts or transplants. Its competitors include: AbioMed, Inc., Berlin Heart GmbH, CardioKinetix, Inc., CircuLite, Inc. & HeartWare International Inc. Its business is subject to extensive federal and state government regulation.

Ratios

vs
industry
vs
history
P/B 3.60
SSH's P/B is ranked lower than
55% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 3.05 vs. SSH: 3.60 )
Ranked among companies with meaningful P/B only.
SSH' s P/B Range Over the Past 10 Years
Min: 0.74  Med: 2.34 Max: 3.67
Current: 3.6
0.74
3.67
Current Ratio 1.78
SSH's Current Ratio is ranked lower than
72% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 2.56 vs. SSH: 1.78 )
Ranked among companies with meaningful Current Ratio only.
SSH' s Current Ratio Range Over the Past 10 Years
Min: 1.06  Med: 10.33 Max: 63.13
Current: 1.78
1.06
63.13
Quick Ratio 1.78
SSH's Quick Ratio is ranked lower than
55% of the 317 Companies
in the Global Medical Devices industry.

( Industry Median: 1.94 vs. SSH: 1.78 )
Ranked among companies with meaningful Quick Ratio only.
SSH' s Quick Ratio Range Over the Past 10 Years
Min: 1.06  Med: 10.33 Max: 63.13
Current: 1.78
1.06
63.13

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -25.50
SSH's 3-Year Average Share Buyback Ratio is ranked lower than
86% of the 211 Companies
in the Global Medical Devices industry.

( Industry Median: -3.40 vs. SSH: -25.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SSH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -112  Med: -38.4 Max: 0
Current: -25.5
-112
0

Valuation & Return

vs
industry
vs
history
Price/Net Cash 4.81
SSH's Price/Net Cash is ranked higher than
84% of the 96 Companies
in the Global Medical Devices industry.

( Industry Median: 16.44 vs. SSH: 4.81 )
Ranked among companies with meaningful Price/Net Cash only.
SSH' s Price/Net Cash Range Over the Past 10 Years
Min: 2.2  Med: 2.82 Max: 31.61
Current: 4.81
2.2
31.61
Price/Net Current Asset Value 4.51
SSH's Price/Net Current Asset Value is ranked higher than
69% of the 201 Companies
in the Global Medical Devices industry.

( Industry Median: 7.11 vs. SSH: 4.51 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
SSH' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 2.16  Med: 2.82 Max: 163
Current: 4.51
2.16
163
Price/Tangible Book 3.60
SSH's Price/Tangible Book is ranked higher than
56% of the 261 Companies
in the Global Medical Devices industry.

( Industry Median: 4.42 vs. SSH: 3.60 )
Ranked among companies with meaningful Price/Tangible Book only.
SSH' s Price/Tangible Book Range Over the Past 10 Years
Min: 2.02  Med: 2.65 Max: 31.65
Current: 3.6
2.02
31.65
Earnings Yield (Greenblatt) (%) -250.00
SSH's Earnings Yield (Greenblatt) (%) is ranked lower than
99% of the 308 Companies
in the Global Medical Devices industry.

( Industry Median: 0.60 vs. SSH: -250.00 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
SSH' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -250  Med: 1194.3 Max: 9433.2
Current: -250
-250
9433.2

More Statistics

EPS (TTM) $ -1.21
Beta2.68
Short Percentage of Float4.40%
52-Week Range $0.40 - 2.82
Shares Outstanding (Mil)20.41

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 2 8 13
EPS ($) -0.87 -0.76 -0.68
EPS w/o NRI ($) -0.87 -0.76 -0.68
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for NAS:SSH

Headlines

Articles On GuruFocus.com

More From Other Websites
4:31 pm Sunshine Heart announces receipt of Nasdaq Staff Determination for bid price requirement ;... Sep 25 2016
Sunshine Heart Announces Receipt of Nasdaq Staff Determination; To Request Hearing Sep 23 2016
SUNSHINE HEART, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Sep 23 2016
Sunshine Heart Announces Receipt of Nasdaq Staff Determination; To Request Hearing Sep 23 2016
Sunshine Heart Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Aug 25 2016
Sunshine Heart Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Aug 25 2016
SUNSHINE HEART, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Aug 24 2016
SUNSHINE HEART, INC. Financials Aug 18 2016
Sunshine Heart to Present at the 2016 investMNt Conference on August 24, 2016 Aug 18 2016
Sunshine Heart to Present at the 2016 investMNt Conference on August 24, 2016 Aug 18 2016
Sunshine Heart Appoints Megan Brandt as Vice President, Regulatory Affairs and Quality Assurance Aug 16 2016
Sunshine Heart Appoints Megan Brandt as Vice President, Regulatory Affairs and Quality Assurance Aug 16 2016
SUNSHINE HEART, INC. Files SEC form 10-Q, Quarterly Report Aug 11 2016
Q2 2016 Sunshine Heart Inc Earnings Release - Before Market Open Aug 09 2016
SUNSHINE HEART, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 09 2016
Sunshine Heart Announces Second Quarter 2016 Financial Results and Provides Company Update Aug 09 2016
Sunshine Heart reports 2Q loss Aug 09 2016
Sunshine Heart reports 2Q loss Aug 09 2016
Sunshine Heart Announces Second Quarter 2016 Financial Results and Provides Company Update Aug 09 2016
Südwestdeutsche Salzwerke AG :SSH-DE: Earnings Analysis: For the six months ended December 31, 2015... Aug 09 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)